Quarterly Result29 May 2026, 03:44 pm
3B BlackBio Dx: FY26 Revenue ₹9727.50 Lakhs
AI Summary
3B BlackBio Dx Ltd's board approved and recorded the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of 50%, i.e., ₹5.00 per equity share of ₹10 each, subject to shareholder approval. M/s Ali Jain & Sharma, Chartered Accountants, Bhopal, were appointed as Internal Auditor for FY 2026-27. The company reported revenue from operations of ₹9727.50 lakhs and a profit after tax of ₹4931.69 lakhs for the year ended March 31, 2026.
Key Highlights
- Audited FY26 results approved with revenue from operations at ₹9727.50 lakhs.
- Board recommends a final dividend of ₹5.00 per share (50%) for FY26.
- Ali Jain & Sharma appointed as Internal Auditor for FY27.
- Profit after tax for FY26 stands at ₹4931.69 lakhs.
- Auditors, Baheti & Company, issued an unmodified opinion on financial results.
Price Impact
More from KILPEST